<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7004585/results/search/drug/results.xml">
  <result pre=": 3800: Research ArticleStudy Protocol Systematic Review Kushenin combined with" exact="entecavir" post="for chronic hepatitis BA protocol for a systematic review"/>
  <result pre="evaluate the efficacy and safety of kushenin (KS) combined with" exact="entecavir" post="(ETV) for chronic hepatitis B. Methods: Randomized controlled trials"/>
  <result pre="for CHB. PROSPERO registration number: CRD42019124790. Keywords chronic hepatitis B" exact="entecavir" post="kushenin meta-analysis oxymatrine protocol 1 Introduction More than 240"/>
  <result pre="hepatitis B virus surface antigen (HBsAg) transcription is very limited.[2]" exact="Entecavir" post="(ETV) is one of the preferred antiviral agents for"/>
  <result pre="serum HBV-DNA for more than half a year, elevated serum" exact="alanine" post="aminotransferase (ALT) level, there is no limitation on the"/>
  <result pre="clinical treatment of CHB. Author contributions None. Abbreviations: ALT =" exact="alanine" post="aminotransferase, CHB = chronic hepatitis B, CI = confidence"/>
  <result pre="J, Jin Y, Xiao X, Zhang Q. Kushenin combined with" exact="Entecavir" post="for chronic hepatitis B: A protocol for a systematic"/>
 </snippets>
</snippetsTree>
